PL3194618T3 - Kompozycje, sposoby i zestawy do diagnozy nowotworu neuroendokrynnego żołądkowo- jelitowo-trzustkowego - Google Patents

Kompozycje, sposoby i zestawy do diagnozy nowotworu neuroendokrynnego żołądkowo- jelitowo-trzustkowego

Info

Publication number
PL3194618T3
PL3194618T3 PL15771837T PL15771837T PL3194618T3 PL 3194618 T3 PL3194618 T3 PL 3194618T3 PL 15771837 T PL15771837 T PL 15771837T PL 15771837 T PL15771837 T PL 15771837T PL 3194618 T3 PL3194618 T3 PL 3194618T3
Authority
PL
Poland
Prior art keywords
kits
diagnosis
compositions
methods
gastroenteropancreatic neuroendocrine
Prior art date
Application number
PL15771837T
Other languages
English (en)
Polish (pl)
Inventor
Irvin Mark MODLIN
Mark Kidd
Ignat Drozdov
Original Assignee
Clifton Life Sciences LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clifton Life Sciences LLC filed Critical Clifton Life Sciences LLC
Publication of PL3194618T3 publication Critical patent/PL3194618T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57557—Immunoassay; Biospecific binding assay; Materials therefor for cancer of other specific parts of the body, e.g. brain
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
    • C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
    • C12Q2537/143—Multiplexing, i.e. use of multiple primers or probes in a single reaction, usually for simultaneously analyse of multiple analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/107—Nucleic acid detection characterized by the use of physical, structural and functional properties fluorescence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PL15771837T 2014-09-15 2015-09-15 Kompozycje, sposoby i zestawy do diagnozy nowotworu neuroendokrynnego żołądkowo- jelitowo-trzustkowego PL3194618T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462050465P 2014-09-15 2014-09-15
EP15771837.0A EP3194618B1 (en) 2014-09-15 2015-09-15 Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm
PCT/US2015/050274 WO2016044330A1 (en) 2014-09-15 2015-09-15 Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm

Publications (1)

Publication Number Publication Date
PL3194618T3 true PL3194618T3 (pl) 2021-12-13

Family

ID=54207775

Family Applications (2)

Application Number Title Priority Date Filing Date
PL15771837T PL3194618T3 (pl) 2014-09-15 2015-09-15 Kompozycje, sposoby i zestawy do diagnozy nowotworu neuroendokrynnego żołądkowo- jelitowo-trzustkowego
PL21169154.8T PL3929303T3 (pl) 2014-09-15 2015-09-15 Kompozycje, sposoby i zestawy do diagnozy nowotworu neuroendokrynnego żołądkowo-jelitowo-trzustkowego

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL21169154.8T PL3929303T3 (pl) 2014-09-15 2015-09-15 Kompozycje, sposoby i zestawy do diagnozy nowotworu neuroendokrynnego żołądkowo-jelitowo-trzustkowego

Country Status (13)

Country Link
US (4) US10407730B2 (cg-RX-API-DMAC7.html)
EP (2) EP3194618B1 (cg-RX-API-DMAC7.html)
JP (2) JP6782700B2 (cg-RX-API-DMAC7.html)
KR (2) KR102762958B1 (cg-RX-API-DMAC7.html)
CN (1) CN107208132A (cg-RX-API-DMAC7.html)
AU (3) AU2015317893B2 (cg-RX-API-DMAC7.html)
CA (1) CA2959670C (cg-RX-API-DMAC7.html)
DK (2) DK3929303T3 (cg-RX-API-DMAC7.html)
ES (2) ES3013599T3 (cg-RX-API-DMAC7.html)
IL (2) IL250867B (cg-RX-API-DMAC7.html)
MX (2) MX386919B (cg-RX-API-DMAC7.html)
PL (2) PL3194618T3 (cg-RX-API-DMAC7.html)
WO (1) WO2016044330A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10407730B2 (en) 2014-09-15 2019-09-10 Clifton Life Sciences LLC Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm
MX2019014026A (es) * 2017-05-25 2020-08-03 Liquid Biopsy Res Llc Metodos para la deteccion de melanoma.
CN118910259A (zh) * 2017-11-30 2024-11-08 液体活检研究有限责任公司 使用基因表达测定预测肽受体放射治疗
CN108048564B (zh) * 2018-02-09 2021-03-05 中国科学院昆明动物研究所 人glt8d1基因的新用途
US11948296B2 (en) * 2018-07-30 2024-04-02 Agency For Science, Technology And Research Method and system for assessing fibrosis in a tissue sample
EP4041886A1 (en) 2019-10-10 2022-08-17 Liquid Biopsy Research LLC Compositions, methods and kits for biological sample and rna stabilization
FR3110764B1 (fr) 2020-05-20 2024-05-10 Quantum Surgical Méthode de prédiction de la récidive d’une lésion par analyse d’images
CN113215255B (zh) * 2021-04-26 2022-04-05 山东天川精准医疗科技有限公司 用于肝癌早期诊断或预后的生物标记物及其用途
CN120153081A (zh) * 2022-07-15 2025-06-13 埃门多生物公司 Aplp2安全港位点敲入策略
CN120380169A (zh) * 2022-09-30 2025-07-25 液体活检研究有限责任公司 用于在唾液中检测神经内分泌癌的方法
CN117292755B (zh) * 2023-08-09 2026-02-06 郑州大学 多模态临界边生物标志物识别方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050084883A1 (en) 2003-08-25 2005-04-21 The Johns Hopkins University School Of Medicine Method of diagnosis and treatment of pancreatic endocrine neoplasms based on differential gene expression analysis
JP5728380B2 (ja) * 2008-06-12 2015-06-03 シンタクシン リミテッドSyntaxin Limited 神経内分泌疾患の抑制
AU2012223288B2 (en) 2011-03-01 2017-03-30 Yale University Predicting gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs)
US10407730B2 (en) 2014-09-15 2019-09-10 Clifton Life Sciences LLC Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm

Also Published As

Publication number Publication date
AU2015317893A1 (en) 2017-03-23
US20260043085A1 (en) 2026-02-12
JP7157788B2 (ja) 2022-10-20
KR20170045365A (ko) 2017-04-26
IL281355B (en) 2022-02-01
JP2021019618A (ja) 2021-02-18
IL281355A (en) 2021-04-29
KR20250021631A (ko) 2025-02-13
US20220325351A1 (en) 2022-10-13
AU2021212151A1 (en) 2021-08-26
MX386919B (es) 2025-03-19
BR112017005279A2 (pt) 2017-12-12
CA2959670A1 (en) 2016-03-24
DK3929303T3 (da) 2025-03-03
AU2023258444A1 (en) 2023-11-23
MX2017003370A (es) 2017-11-22
US10407730B2 (en) 2019-09-10
EP3194618A1 (en) 2017-07-26
US11168372B2 (en) 2021-11-09
US20190345568A1 (en) 2019-11-14
AU2015317893B2 (en) 2021-05-20
AU2021212151B2 (en) 2023-08-03
EP3929303A1 (en) 2021-12-29
CA2959670C (en) 2024-02-20
JP6782700B2 (ja) 2020-11-11
CN107208132A (zh) 2017-09-26
PL3929303T3 (pl) 2025-04-28
US12258633B2 (en) 2025-03-25
EP3194618B1 (en) 2021-04-21
MX2021012347A (es) 2021-10-22
IL250867A0 (en) 2017-04-30
JP2017528164A (ja) 2017-09-28
DK3194618T3 (da) 2021-07-12
WO2016044330A1 (en) 2016-03-24
EP3929303B1 (en) 2024-12-04
ES3013599T3 (en) 2025-04-14
KR102762958B1 (ko) 2025-02-04
IL250867B (en) 2021-03-25
ES2881474T3 (es) 2021-11-29
US20160076106A1 (en) 2016-03-17

Similar Documents

Publication Publication Date Title
PL3929303T3 (pl) Kompozycje, sposoby i zestawy do diagnozy nowotworu neuroendokrynnego żołądkowo-jelitowo-trzustkowego
EP3185748A4 (en) Evaluating test taking
GB2524479B (en) Testing rig
GB201403096D0 (en) Sample preparation method
EP3121586A4 (en) Fatigue tester
EP3093668A4 (en) Automated analyzer
EP3176587A4 (en) Automated analyzer
GB201411060D0 (en) Improved immunoassay method
GB201421920D0 (en) Software test automation
IL246889A0 (en) A method for measuring engagement
ZA201606324B (en) Method for diagnosing tuberculosis
GB2528376B (en) Lubricant test method
EP3136101A4 (en) Method of testing for pulmonary hypertension
AU2015343095B2 (en) Application testing
EP3225995A4 (en) Inspection kit
ZA201900570B (en) Methods for gynecologic neoplasm diagnosis
EP3188701A4 (en) Reduction kits
GB201615417D0 (en) Fluoometric analyzer
ZA201607571B (en) Compositions and methods for detecting huanglongbing
EP3137874B8 (fr) Procédé de diagnostic de la méningite
GB201400756D0 (en) Blisk
EP3137886A4 (en) Xrf analyzer
GB2548042B (en) Real-time performance analyzer for drilling operations
EP3174377A4 (en) Inspection method
GB201414419D0 (en) Method of testing